Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
On 3 December, innovative pharmaceutical trade associations issued a joint statement on the Declaration on Climate and Health at COP28.
The innovative pharmaceutical industry commends the ambition to address climate change as an urgent health challenge at COP28, including through the agreement of the first ever Declaration on Climate and Health.
Pharmaceutical companies continue to be at the forefront of setting ambitious net-zero and carbon-neutrality targets, acting as part of global initiatives to reduce carbon emissions throughout their operations and value chains. To deliver on these targets, companies are investing in research and development with a view to delivering more environmentally sustainable products, manufacturing processes, and supply chains.
The complex and highly regulated nature of pharmaceutical products means that a high degree of coordination and collaboration between industry, governments, and healthcare systems is required.
As such, collaboration across UN institutions, such as the World Health Organization (WHO) and the United Nations Framework Convention on Climate Change (UNFCCC), government, civil society, and private sector will be essential in meeting theses ambitions. We therefore welcome the WHO Alliance for Transformative Action on Climate and Health (ATACH) as an important platform for mobilizing the resources, knowledge, and expertise required to effectively address the climate and health crisis.
Investment in science and research, alongside coordinated global cooperation, will continue to be central in delivering on our shared climate commitments and those set out at COP28.
a joint statement BY:
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
